Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

NCT: NCT04206215 · RECRUITING

NCT IDNCT04206215
StatusRECRUITING
Start Date2021-04-16
Completion2027-12-28
SponsorSpaulding Rehabilitation Hospital (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain in subjects with Carpal Tunnel Syndrome. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.

Frequently Asked Questions

What is Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome?

Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome is a clinical trial registered under NCT04206215. Current status: RECRUITING.

What is the status of NCT04206215?

The current status of NCT04206215 (Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome) is: RECRUITING.

When did Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome start?

Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome started on 2021-04-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.